Effect of aclidinium bromide on dyspnoea and health status in patients with stable COPD: Phase III data by GOLD 2013 classification

被引：0
|
作者：
Mroz, Robert M.
Ausin, Maria Pilar
Lamarca, Rosa
Gil, Esther Garcia
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2014年 / 44卷
关键词：
Bronchodilators; COPD; -; management;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P891
引用
收藏
页数：4
相关论文
共 25 条
  • [1] Efficacy of aclidinium bromide in patients with stable COPD: Pooled analysis of phase III data by GOLD 2013 criteria
    Thomas, Mike
    Price, David
    Segarra, Rosa
    Gil, Esther Garcia
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [2] Analysis of comorbidities and treatment patterns by GOLD 2013 criteria: Pooled data from Phase III aclidinium bromide studies
    Price, David
    Thomas, Mike
    Lamarca, Rosa
    Gil, Esther Garcia
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [3] Effect of aclidinium bromide on exacerbations in patients with moderate-to-severe COPD: Pooled analysis of phase III studies
    Wedzicha, Jadwiga A.
    Donaldson, Gavin
    Chuecos, Ferran
    Gil, Esther Garcia
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [4] EFFECT OF GLYCOPYRRONIUM ON LUNG FUNCTION, DYSPNOEA AND HEALTH STATUS IN COPD PATIENTS IN ALL GOLD GROUPS
    Goyal, Pankaj
    D'Urzo, Anthony
    Bader, Giovanni
    Altman, Pablo
    RESPIROLOGY, 2015, 20 : 42 - 42
  • [5] REDUCED COPD EXACERBATIONS ASSOCIATED WITH ACLIDINIUM BROMIDE VERSUS PLACEBO: A POOLED ANALYSIS OF PHASE III DATA
    Jones, Paul W.
    Singh, Dave
    Kerwin, Edward
    Lamarca, Rosa
    Caracta, Cynthia
    Garcia Gil, Esther
    THORAX, 2012, 67 : A146 - A146
  • [6] The effect of twice-daily aclidinium bromide on cough and sputum in patients with COPD: Results from phase III studies
    McGarvey, Lorcan
    Morice, Alyn
    Smith, Jacky
    Birring, Surinder
    Chuecos, Ferrari
    Seoane, Beatriz
    Jarreta, Diana
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [7] A Phase III Study Evaluating Aclidinium Bromide, a Novel Long-Acting Antimuscarinic, in Patients with COPD: ACCLAIM/COPD I
    Jones, P. W.
    Agusti, A.
    Chanez, P.
    Magnussen, H.
    Fabbri, L.
    Maroni, J.
    Garcia-Gil, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [8] A PHASE III STUDY EVALUATING ACLIDINIUM BROMIDE, A NOVEL LONG-ACTING ANTIMUSCARINIC, IN PATIENTS WITH COPD: ACCLAIM/COPD I
    Jones, P. W.
    Chanez, P.
    Agusti, A.
    Magnussen, H.
    Fabbri, L.
    Caracta, C.
    Garcia Gil, E.
    THORAX, 2009, 64 : A168 - A168
  • [9] Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials
    McGarvey, Lorcan
    Morice, Alyn H.
    Smith, Jaclyn A.
    Birring, Surinder S.
    Chuecos, Ferran
    Seoane, Beatriz
    Jarreta, Diana
    BMJ OPEN RESPIRATORY RESEARCH, 2016, 3 (01):
  • [10] Efficacy and Safety of the Novel, Long-Acting Antimuscarinic, Aclidinium Bromide, in COPD Patients in a Phase III Study: ACCLAIM/COPD II
    Rennard, S.
    Donohue, J.
    Bateman, E.
    Gross, N.
    Garcia Gil, E.
    Caracta, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
123